Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
EuroIntervention · 2023
DOI: 10.4244/eij-d-22-00526 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2023. Verfasst von Ton Slagboom und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, OLVG, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Coronary Artery Disease, Drug-Eluting Stents, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardiology Unit, OLVG, Amsterdam, the Netherlands.
- Herzzentrum, Segeberger Kliniken, Bad Segeberg, Germany.
- Department of Cardiology and Pneumology, Helios Amper-Klinikum, Dachau, Germany.
- Lukaskrankenhaus Medizinische Klinik I, Städtische Kliniken Neuss, Neuss, Germany.
- Department of Cardiology, Hospital Clínic de Barcelona, Barcelona, Spain.
- Haemodynamic Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
Zitieren
APA
Slagboom, T., Toelg, R., Witzenbichler, B., Haude, M., Masotti, M., Ruiz Salmeron, R., Witkowski, A. R., Uematus, M., Takahashi, A., Waksman, R., & Saito, S. (2023). Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial. EuroIntervention. https://doi.org/10.4244/eij-d-22-00526
Vancouver
Slagboom T, Toelg R, Witzenbichler B, Haude M, Masotti M, Ruiz Salmeron R, et al. Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial. EuroIntervention. 2023. doi:10.4244/eij-d-22-00526
BibTeX
@article{Slagboom2023,
author = {Slagboom, Ton and Toelg, Ralph and Witzenbichler, Bernhard and Haude, Michael and Masotti, Monica and Ruiz Salmeron, Rafael and Witkowski, Adam Ryszard and Uematus, Masaaki and Takahashi, Akihiko and Waksman, Ron and Saito, Shigeru},
title = {Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial},
journal = {EuroIntervention},
year = {2023},
doi = {10.4244/eij-d-22-00526}
}
EUVIMED